FDA approves new kidney procedure to lower blood pressure by disrupting overactive nerves.

A new treatment called renal denervation offers hope for patients with high blood pressure that remains uncontrolled despite multiple medications. Approved by the FDA, the minimally invasive procedure involves threading a catheter to the kidneys and using energy to disrupt overactive nerves. Studies show an average 8-10 point drop in blood pressure, allowing some patients to reduce medication. However, it's not suitable for all, and long-term effects are still unknown.

2 months ago
43 Articles

Further Reading